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Abstract
Objectives: The aim of this study was to analyze the changing trends in surgical treatment of female urinary incon-
tinence (UI).
Material and methods: Medical records of all women admitted to II Department of Gynecology from 1985 to
2006 were analyzed in order to find out how the female SUI treatment changed over these years. 
Results: During analyzed time 36819 patients were hospitalized in our Department and 77.6% (28568) of them
were operated because of various indications. The number of SUI surgeries among all hospitalized women steadily
rose from 1.93% in 1985 to 10.96% in 2006 reaching maximum in 2005 (13.73%). Clinical effectiveness of SUI
surgeries markedly improved from 35% for anterior colporrhaphy to almost 90 % for suburethral slings. 
Conclusions: Introduction into clinical practice modern suburethral slings improved clinical efficacy of SUI treat-
ment. The percentage of women admitted and treated surgically because of SUI steadily increased over the last
years.
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Introduction
Stress urinary incontinence (SUI) is a very common con-
dition, especially in women, and affects almost all aspects of
everyday life, influencing not only affected individuals but also
their families [1]. The exact prevalence rate of this disorder is
not known exactly since different studies have used different
methods of assessment based on design of the questionnaires,
the study population and selection criteria as well [2]. 
However as a rule the prevalence of urinary incontinence
(UI) increases with age, with a typical rate in young adults
around  20 to 30%, a peak around middle age (30–40%) and a
steady increase in old age (30–50%) [3]. 
Our own data estimated the general prevalence rate of UI
among polish women to be 17% with a peak around
menopause with 33% [4]. However, even in Europe the UI
prevalence rate might be different among nations. Recently
published data from four European countries, based on epi-
demiological study from 29 500 community dwelling women
aged 18 years showed the lowest prevalence rate in Spain
(23%), while the prevalence was 44%, 41% and 42% for
France, Germany and the UK, respectively [5]. When type of
incontinence was taken into account the prevalence of stress
symptoms was the highest among all women who reported UI
(all age groups combined) [5]. These findings from European
countries are in agreement with worldwide data previously
presented by Minassian and co-workers [6]. 
The very common occurrence of stress urinary inconti-
nence along with its deleterious influence of everyday life of
affected individuals calls for effective treatment options. This
is of critical importance since SUI can result in a number of
adverse consequences including skin problems, urinary tract
infections, longer hospital stays for non-SUI related condi-
tions and nursing home admissions. Since, as a rule, there is
often a large overlap in urinary symptoms, accurate diagnosis
is mandatory before therapy is instituted because the treat-
ment of each condition may be completely different. 
Usually a conservative approach is advisable initially, espe-
cially if symptoms are only mild, or easily manageable and
surgery should be avoided when a woman’s family is incom-
plete, or when symptoms manifest during pregnancy or soon
after delivery. However surgery for stress urinary incontinence
has been performed on women for almost a century. Since pio-
neer work of Kelly published in 1913 the anterior vaginal
repair used to be the most popular primary procedure for
stress incontinence up to the 1970s, but over the last 20 years
this operation has been criticized because of high recurrence
rates.
Aim
The aim of this study was to analyze the changing trends
in surgical treatment of stress urinary incontinence based on
data from II Department of Gynecology, University School of
Medicine Lublin, Poland.
Material and methods
Medical records of all women admitted to II Department
of Gynecology from 1985 to 2006 were analyzed in order to
elucidate how we treated SUI patients over these time.  
We selected out all performed incontinence surgeries and
divided them according to type of procedure and them clini-
cal efficacy. Data including type of operation performed,
number of operations and number of all patients hospitalized
in particular years as well as percentage of all performed sur-
gical procedures were calculated in analyzed time frame. Chi
square test was used to compare clinical efficacy of various
types of SUI surgeries performed in our Department in years
1985-2006. The p value <0.05 was considered as statistically
significant
Results
Among all gynecological surgeries performed in years
1985-2006 (n= 28568) 7.02% were done due to stress urinary
incontinence (n=2006). (Table I, Figure II). 
The majority of incontinent patients were operated via
vaginal route (n=1773; 88.38%). One hundred twenty five
women (7.05%) underwent classical Burch operation, whereas
laparoscopic colposuspension was performed among 108
women (5.38%). 
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Streszczenie
Cel pracy: Celem pracy by∏o przeprowadzenie retrospektywnej analizy metod operacyjnego leczenia wysi∏kowego
nietrzymania moczu (WNM) u kobiet na przestrzeni ostatnich dwudziestu dwóch lat.
Materia∏ i metody: Dane do analizy pozyskano z archiwum medycznego II Kliniki Ginekologii i na ich podstawie
przedstawiono zmiany w operacyjnym leczeniu WNM u kobiet od 1985 do 2006 roku.
Wyniki: W analizowanym okresie, w II Klinice hospitalizowanych by∏o 36819 kobiet, z czego 77,6% (28568) by∏o
operowanych z powodu ró˝nych wskazaƒ. Liczba pacjentek operowanych z powodu WNM stale ros∏a od 1,93% w
1985r. do 10,96% w 2006r. ze szczytem w 2005r. (13,73%). Równie˝ skutecznoÊç zabiegów znacznie wzros∏a z
35% w przypadku ró˝nych modyfikacji plastyki przedniej Êciany pochwy do niemal 90% przy zastosowaniu taÊm
podcewkowych.
Wnioski: Wprowadzenie nowoczesnych, ma∏oinwazyjnych taÊm podcewkowych znaczàco zwi´kszy∏o efektywnoÊç
operacyjnego leczenia WNM. Wydaje si´ to byç jednà z przyczyn sta∏ego wzrostu liczby kobiet decydujàcych si´ na
tà metod´ leczenia tej dolegliwoÊci.
S∏owa kluczowe: wysi∏kowe nietrzymanie moczu / operacyjne leczenie WNM /
/ taÊmy podcewkowe /
We observed a steadily raising trend in number of patients
operated due to SUI in our Department from 31 (1.93% of all
hospital admissions in 1985) to 238 (10.96% of all admissions
in 2006). (Table II, Figure 1).  
From 1985 to 1997 the dominant type of procedure was
anterior colporrhaphy (various modifications) despite its
unacceptable clinical efficacy. (Table III and IV). 
This trend has changed in 1998 after introduction to our
clinical practice laparoscopic Burch colposuspension with
much better clinical outcome. (Table III). 
The new era of minimally invasive surgical treatment of
female SUI in our Department started in year 2000 with the
introduction suburethral sling operations. (Table I and III).
Smaller number of patients hospitalized as well as surger-
ies performed in 2005 was due to renovation works in our
Department lasting from 14th of October till 31st December.
The clinical outcome of different type of surgeries used in the
treatment of female stress urinary incontinence clearly show
that anterior colporrhaphy should be abandoned in the treat-
ment of this condition. (Table IV). 
Discussion
It should be stressed that the mainstay of initial therapy
for stress incontinence is pelvic floor physiotherapy. This
should routinely be used as the first-line treatment. The
advantage of this approach is that many women can be cured
or improved to the point they do not require surgery, with its
potential complications. Recently, a new drug has been deve-
loped, specifically for the treatment of stress incontinence.
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Table I. All analyzed data from medical records since 1985.
1985 31 0 0 0 3 0 0 0 0 0 31 1265 1603 78,9
1986 24 0 0 0 1 0 0 0 0 0 24 1278 1628 78,5
1987 17 0 0 0 2 0 0 0 0 0 17 1125 1592 70,7
1988 34 0 0 0 2 0 0 0 0 0 34 1207 1598 75,5
1989 48 0 0 0 1 0 0 0 0 0 48 1247 1553 80,3
1990 38 0 0 0 4 0 0 0 0 0 38 1270 1631 77,9
1991 57 0 0 0 6 0 0 0 0 0 57 1262 1664 75,8
1992 45 0 0 0 3 0 0 0 0 0 45 1281 1671 76,7
1993 43 0 0 0 4 0 0 0 0 0 43 1249 1687 74,0
1994 69 0 0 0 8 0 0 0 0 0 69 1302 1747 74,5
1995 58 0 0 0 7 0 0 0 0 0 58 1256 1652 76,0
1996 31 0 14 6 4 0 0 0 0 0 51 1198 1723 69,5
1997 41 0 15 28 4 0 0 0 0 0 84 1203 1691 71,1
1998 8 0 11 58 1 1 0 0 0 0 78 1228 1638 75,0
1999 6 1 10 16 0 11 0 0 0 0 44 1257 1555 80,8
2000 4 0 2 0 0 90 0 0 0 0 96 1234 1551 79,6
2001 3 0 4 0 0 159 0 0 0 0 166 1292 1631 79,2
2002 1 0 12 0 0 9 152 0 0 0 174 1350 1769 76,3
2003 3 0 9 0 0 22 156 0 0 0 190 1476 1760 83,9
2004 0 0 20 0 0 4 71 114 0 0 209 1513 1760 86,0
2005 0 0 15 0 0 1 182 0 24 0 212 1383 1544 89,5
2006 0 0 13 0 0 3 212 0 6 4 238 1692 2171 77,9
Total 511 1 125 108 50 300 763 114 30 4 2006 28568 36819
Figure 1. Number of surgeries in stress urinary incontinence.
Duloxetine is a potent serotonin and noradrenaline reuptake
inhibitor (SNRI) that enhances urethral striated sphincter
activity via a centrally mediated pathway [7]. 
The clinical data strongly suggests that duloxetine is an
effective alternative to surgery and may be complimentary to
the use of physiotherapy in the initial management of women
with stress incontinence [8, 9]. 
However surgery remains the cornerstone of treatment for
women with a diagnosis of severe SUI and also in those who
have failed to improve with conservative methods. 
Among surgical procedures used in SUI treatment are:
anterior colporrhaphy and its various modifications,
Marschall-Marchetti-Krantz (MMK) and Burch colposus-
pension with its laparoscopic modifications, paravaginal
repair, needle suspension procedures, sling procedures (using
autologous and synthetic materials), injectable agents and
artificial sphincters. 
As it was shown in Table I and III not all these procedures
were used in our Department during analyzed time period.
Unfortunately, the anterior colporrhaphy procedure with
bladder buttress in many gynecological (but not urogyneco-
logical) departments still remains the most common surgery
for urodynamic stress incontinence. 
However, case report literature indicates a wide range of
continence rates following this procedure, ranging from 31%
to 100% [10]. 
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1985 12 8 8
1986 13 6 4
1987 10 2 3
1988 18 7 7
1989 28 8 11
1990 18 12 4
1991 30 18 3
1992 25 13 4
1993 24 14 1
1994 36 18 7
1995 29 15 7
1996 15 11 1
1997 18 15 4
1998 2 5 0
1999 1 5 0
2000 3 1 0
2001 2 1 0
2002 0 1 0
2003 2 1 0
2004 0 0 0
2005 0 0 0
2006 0 0 0
Total 286 161 64
Anterior colporrhaphy 511








1985 31 1603 1,93
1986 24 1628 1,47
1987 17 1592 1,06
1988 34 1598 2,12
1989 48 1553 3,09
1990 38 1631 2,32
1991 57 1664 3,42
1992 45 1671 2,69
1993 43 1687 2,54
1994 69 1747 3,95
1995 58 1652 3,51
1996 51 1723 2,96
1997 84 1691 4,97
1998 78 1638 4,76
1999 44 1555 2,83
2000 96 1551 6,19
2001 166 1631 10,17
2002 174 1769 9,84
2003 190 1760 10,79
2004 209 1760 11,87
2005 212 1544 13,73
2006 238 2171 10,96
Total 2006 36819
Mean % 5,32
Table II. The percentage of women suffering from SUI among all
treated women.
YEAR
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patients
Tabela IV. Clinical outcome of different types of  surgeries. 
Type of surgery
Number of surgeries










































We do not included in current analysis recently introduced new, microinvasive methods like TFS or TVT Secure
because of relatively small number of operated patients and short observation time.
This was also the case in our series where only 35% of
patients remained dry after 5 years of observation. Of course
it should be stressed that this kind of procedure is character-
ized by very low morbidity rate but its very low efficacy clear-
ly disqualify it as a method of choice for female SUI treat-
ment. Few meta-analyses suggest a continence rate after ante-
rior repair raging from 67.8% to 72.0% although this method
is not recommended by current therapeutical guidelines [11,
13]. Randomized trials including anterior colporrhaphy in one
arm and suprapubic surgery in the other show a continence
rate of 66% for vaginal repair [12]. According to experts from
the American Urological Association so called “anterior
repairs” are the least likely, of the four major operative cate-
gories (anterior repair, suburethral sling, colposuspension,
long-needle suspension), to be efficacious in the long term
[13]. This was definitely the main reason that we changed our
surgical practice when concerning incontinent women and as
a consequence anterior colporrhaphy was abandoned since
1998 as a method o SUI treatment in our Department. 
However it should be mentioned that since the most accu-
rate operation for the woman with stress incontinence in the
presence of anterior wall prolapse is currently unclear anteri-
or repair still remains a surgical option for the correction ante-
rior vaginal wall anatomy. The place of Burch colposuspen-
sion among other continence procedures was a topic of a
Cochrane review in 2003 [14]. The authors concluded that
open Burch colposuspension is the most effective surgical
treatment for stress incontinence, especially in the long term.
Data from 33 trials involving 2403 women clearly shown that
Burch colposuspension is more effective than needle suspen-
sion (14% subjective failure after one year for open colposus-
pension compared with 26% for needle suspension) and pro-
vides a similar subjective continence rate to laparoscopic col-
posuspension (85-100% after 6-18 months of follow-up). Sim-
ilarly, even when compared to the recently most popular sub-
urethral sling procedures, colposuspension either open or
laparoscopical show a similar continence rate [15, 16]. 
Moreover, there was no evidence of increased morbidity
or complication rate associated with open colposuspension
compared with other techniques, although posterior pelvic
organ prolapse is more common than after anterior colpor-
rhaphy and sling procedures. We performed laparoscopic
Burch colposuspension almost routinely in women with uro-
dynamically proven stress urinary incontinence in 1997 and
1998, but finally we abandoned it since TVT was introduced
into clinical practice in our Department [17, 18]. 
The main reasons for this was technical simplicity of sub-
urethral slings accompanied by very high clinical efficacy par-
alleled by very low complications rate. The use of sling proce-
dures in the treatment of stress incontinence was first
described over 100 years ago, but these procedures were not
very popular until the tension-free vaginal tape (TVT) was
introduced into clinical practice by Petros and Ulmsten in
1995 [19]. 
Nowadays, all suburethral sling operations are based on
“tension free principles” and that means that tapes are placed
beneath the urethra without any additional fixation. As it was
shown, we routinely use sling operations (TVT and IVS) since
2000 with very high success rates and low complications rates
[20]. In 2001 Delorme first described the method of tape
placement through obturator foramen with possible advan-
tage over retropubic route in decreasing complications rate
without loosing clinical efficacy [21]. Based on very encourag-
ing preliminary reports since the beginning of 2004 we almost
replaced retropubic procedures in favor to transobturator one
and this enable us to reduce intraoperational complications
while maintaining efficacy [22]. 
Currently numerous autologous and synthetic materials or
even xenografts are available for use in a suburethral sling with
polypropylene tapes being the most popular. Overall, with all
of these materials the risk of vaginal erosion ranges from zero
to approximately 16%, urethral erosion from 0 to 5%, de novo
detrusor overactivity from 3.7 to 66.0%, and procedures
requiring sling revision or removal range from 1.8 to 35% [23].
When compared with colposuspension procedures, the
suburethral sling carries a similar success rate but the surgical
technique is much simpler and therefore learning curve much
shorter [12]. This appears to be true even in patients with low
maximal urethral closure pressure [24]. It should be noted that
The Second International Consultation on Incontinence con-
cluded that suburethral slings represented an effective proce-
dure for genuine stress incontinence also in the presence of
previous failed surgery [12]. 
Nowadays, it is obligatory that women undergoing surgery
for stress incontinence should have urodynamic investigations
(including cystometry) prior to treatment, and this opinion
was also recently stated by experts of Polish Gynecological
Society [25]. Since 1999 we follow strictly this procedure. It
seems prudent prior to performing irreversible bladder-neck
surgery to have assessed objectively the type of incontinence
and the presence of any complicating factors such as voiding
difficulty or detrusor overactivity. One should remember that
urodynamic findings often may affect the surgical decision
and provide solid basis for informed consent. And last but not
least, surgery should be performed by a surgeon who has been
trained in the operation and who has a caseload that enables
him or her to provide a suitable level of expertise since the best
chance of surgical ‘cure’ for stress incontinence is successful
primary surgery. Of course the proper surgical training is espe-
cially important when any repeat surgery is considered. 
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Changing trends in the surgical treatment of female stress urinary incontinence ...
Figure 2. Number of different types of urinary incontinence surgeries.
Conclusions
1. Steady increase of number of patients operated due to SUI
in our Department was observed during last 22 years.
2. Anterior colporrhaphy because of unacceptable low clinical
efficacy should be abandoned as a method of SUI treat-
ment.
3. Current state of the art in the field of continence surgery are
minimally invasive suburethral slings because of their tech-
nical simplicity accompanied by high clinical efficacy and
low complications rates. 
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Aktualne poglàdy dotyczàce leczenia
chorych z b∏oniakiem ziarnistym jajnika 
Current views on treatment of the ovarian granulosa-cell tumor
Grabiec Marek1, Kwiatkowski Mariusz2, Walentowicz Ma∏gorzata1,Gr´êlikowska Urszula1
1 Katedra i Klinika Ginekologii Onkologicznej i Piel´gniarstwa Ginekologicznego UMK w Toruniu 
Collegium Medicum im. Ludwika Rydygiera w Bydgoszczy
2 Oddzia∏ Kliniczny Onkologii Centrum Onkologii w Bydgoszczy
Streszczenie
Ziarniszczak ( b∏oniak ziarnisty, folliculoma ) jest rzadkim nowotworem jajnika i stanowi oko∏o 5% wszystkich guzów
z∏oÊliwych tego narzàdu [1].
Jest najcz´stszym nowotworem wywodzàcym si´ ze sznurów p∏ciowych, stwierdza si´ go w ponad 70% przypad-
ków [1].
B∏oniak ziarnisty nale˝y do guzów hormonalnie czynnych, wywodzi si´ z komórek ziarnistych zr´bu, które produkujà
estradiol. Jego nadmierna sekrecja wywo∏uje szereg objawów klinicznych, które sà pomocne w diagnostyce tego
nowotworu.
Wyró˝niamy dwa typy b∏oniaka ziarnistego: typ m∏odzieƒczy (5%) i typ doros∏ych (95%).
Typ m∏odzieƒczy rozpoznawany jest zazwyczaj (90%) w I stopniu zaawansowania wg FIGO i wià˝e si´ z lepszym
rokowaniem, a zabieg operacyjny jest cz´sto wystarczajàcà metodà leczenia [1]. Guzy w wy˝szym stopniu zaawan-
sowania cechujà si´ bardziej agresywnym przebiegiem z cz´stymi nawrotami i koniecznoÊcià leczenia skojarzonego
[2]
Rozpoznanie ziarniszczaka typu doros∏ych wià˝e si´ z bardziej agresywnym przebiegiem, cz´stszymi nawrotami
i wy˝szà ÊmiertelnoÊcià. Postaç pierwotnie zaawansowana miejscowo nawraca cz´sto wiele lat po zabiegu. Pacjent-
ki z zaawansowanà chorobà wymagajà adjuwantowej radioterapii bàdê chemioterapii [1]. Tak zwane stare leki (po-
chodne platyny) jak i nowe (taksany) wykazujà aktywnoÊç w leczeniu b∏oniaka ziarnistego. 
Aktualnie podstawowym post´powaniem jest chemioterapia wed∏ug schematu BEP (Bleomycyna, Etopozyd,
Cisplatyna). Istnieje jednak koniecznoÊç przeprowadzenia randomizowanych badaƒ klinicznych w celu ustalenia
standardów post´powania u tych chorych.
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